For the Inventor, By the Inventor

Enter assignee name

North Brunswick, NJ, United States of America

Pds Biotechnology Corporation

USPTO Granted Patents = 13

CIPO Patents = 10

EPO Patents = 4

Trademarks = 4

Forward Citations = 186

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Frank Bedu-Addo (12 out of 13 patents)

Leaf Huang (6 out of 42 patents)

Kenya Johnson (6 out of 6 patents)

4. Eric Jacobson (5 out of 8 patents)

5. Gregory Conn (4 out of 4 patents)

6. Samir N Khleif (3 out of 23 patents)

7. Mikayel Mkrtichyan (3 out of 17 patents)

8. Elizabeth Ann Vasievich (3 out of 3 patents)

9. Kenya N Toney Johnson (3 out of 3 patents)

10. Weihsu Claire Chen (3 out of 3 patents)

11. Greg Conn (2 out of 3 patents)

12. Martin Ward (2 out of 3 patents)

13. Jerold Woodward (2 out of 4 patents)

14. Weihsu Chen (2 out of 4 patents)

15. Weili Yan (2 out of 2 patents)

13 patents: Sort by Forward Citations

1. 12201685 - Methods of modulating immune responses with cationic lipid vaccine compositions (2025-01-21),

2. 11911465 - Vaccine compositions and methods of use (2024-02-27),

3. 11911359 - Stimulation of an immune response by cationic lipids (2024-02-27),

4. 11904015 - Vaccine compositions and methods of use (2024-02-20),

5. 11801257 - Stimulation of an immune response by enantiomers of cationic lipids (2023-10-31),

6. 11612652 - Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy (2023-03-28),

7. 11401306 - HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof (2022-08-02),

8. 10828364 - Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions (2020-11-10),

9. 10702541 - Stimulation of an immune response by enantiomers of cationic lipids (2020-07-07),

10. 10286064 - Cationic lipid vaccine compositions and methods of use (2019-05-14),

11. 9789129 - Stimulation of an immune response by enantiomers of cationic lipids (2017-10-17),

12. 8877206 - Stimulation of an immune response by cationic lipids (2014-11-04),

13. 7303881 - Antigen delivery compositions and methods of use (2007-12-04),

Pds Biotechnology Corporation is a clinical-stage immunotherapy company focusing on the development of novel therapies for cancer and infectious diseases. Their platform technology, Versamune, is designed to enhance the body's immune response to target and destroy cancer cells. The company is dedicated to advancing innovative treatments that have the potential to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

13 Patents

#5 in North Brunswick, NJ

#889 in New Jersey

#23,090 in US

#43,583 in the World

North Brunswick, NJ, United States of America

Pds Biotechnology Corporation

Forward Citations = 186

26 inventors:

Frank Bedu-Addo (12 out of 13 patents)

Leaf Huang (6 out of 42 patents)

Kenya Johnson (6 out of 6 patents)

4. Eric Jacobson (5 out of 8 patents)

5. Gregory Conn (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…